Blockchain Registration Transaction Record
GeoVax Labs Announces $4.5 Million Registered Direct Offering for Immunotherapies and Vaccines
GeoVax Labs, Inc. announces a $4.5 million registered direct offering to support the development of immunotherapies and vaccines against cancer and infectious diseases. Learn more about this strategic move and its potential impact on the healthcare industry.

This news matters as it signifies GeoVax Labs, Inc.'s strategic move to secure funding for its clinical-stage biotechnology initiatives. The successful completion of the Offering will enable the company to further develop immunotherapies and vaccines against cancer and infectious diseases, potentially leading to groundbreaking advancements in the healthcare industry.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x93a6e86ade64aa5759f8587a74e67570bb0f749c332c91a2a2356862b5ecec5a |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | file_twz-263189c8059df9b2d9bdec2e6d046143 |